169 related articles for article (PubMed ID: 36370349)
1. Protocol for CRISPR/Cas Genome Editing for Investigating Cell Communication Network.
Okusha Y; Eguchi T
Methods Mol Biol; 2023; 2582():157-167. PubMed ID: 36370349
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles Enriched with Moonlighting Metalloproteinase Are Highly Transmissive, Pro-Tumorigenic, and Trans-Activates Cellular Communication Network Factor (
Okusha Y; Eguchi T; Tran MT; Sogawa C; Yoshida K; Itagaki M; Taha EA; Ono K; Aoyama E; Okamura H; Kozaki KI; Calderwood SK; Takigawa M; Okamoto K
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260433
[TBL] [Abstract][Full Text] [Related]
3. Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene.
Eguchi T; Kubota S; Kawata K; Mukudai Y; Uehara J; Ohgawara T; Ibaragi S; Sasaki A; Kuboki T; Takigawa M
Mol Cell Biol; 2008 Apr; 28(7):2391-413. PubMed ID: 18172013
[TBL] [Abstract][Full Text] [Related]
4. Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.
Wu Q; Jorgensen M; Song J; Zhou J; Liu C; Pi L
Gastroenterol Res Pract; 2016; 2016():2313850. PubMed ID: 27829832
[TBL] [Abstract][Full Text] [Related]
5. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.
Tank J; Lindner D; Wang X; Stroux A; Gilke L; Gast M; Zietsch C; Skurk C; Scheibenbogen C; Klingel K; Lassner D; Kühl U; Schultheiss HP; Westermann D; Poller W
J Mol Cell Cardiol; 2014 Jan; 66():141-56. PubMed ID: 24239602
[TBL] [Abstract][Full Text] [Related]
6. The CCN family of genes: a perspective on CCN biology and therapeutic potential.
Yeger H; Perbal B
J Cell Commun Signal; 2007 Dec; 1(3-4):159-64. PubMed ID: 18568428
[TBL] [Abstract][Full Text] [Related]
7. Ten years later..
Perbal B
J Cell Commun Signal; 2009 Mar; 3(1):1-3. PubMed ID: 19370402
[TBL] [Abstract][Full Text] [Related]
8. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
[TBL] [Abstract][Full Text] [Related]
9. CCN proteins: opportunities for clinical studies-a personal perspective.
Yeger H
J Cell Commun Signal; 2023 Jun; 17(2):333-352. PubMed ID: 37195381
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation.
Schutze N; Noth U; Schneidereit J; Hendrich C; Jakob F
Cell Commun Signal; 2005 Mar; 3(1):5. PubMed ID: 15773998
[TBL] [Abstract][Full Text] [Related]
11. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
12. Targeting CCN Proteins in Rheumatoid Arthritis and Osteoarthritis.
MacDonald IJ; Huang CC; Liu SC; Lin YY; Tang CH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919365
[TBL] [Abstract][Full Text] [Related]
13. Studying the CCN Proteins in Fibrosis.
Hutchenreuther J; Leask A; Thompson K
Methods Mol Biol; 2017; 1489():423-429. PubMed ID: 27734394
[TBL] [Abstract][Full Text] [Related]
14. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 gene.
Chintala H; Liu H; Parmar R; Kamalska M; Kim YJ; Lovett D; Grant MB; Chaqour B
J Biol Chem; 2012 Nov; 287(48):40570-85. PubMed ID: 23048035
[TBL] [Abstract][Full Text] [Related]
16. Transfection, Spinfection, Exofection, and Luciferase Assays for Analysis of CCN Genes Expression Mechanism.
Eguchi T; Lu Y; Taha EA; Okusha Y
Methods Mol Biol; 2023; 2582():103-126. PubMed ID: 36370347
[TBL] [Abstract][Full Text] [Related]
17. Biological characteristics of CCN proteins in tumor development.
Barreto SC; Ray A; Ag Edgar P
J BUON; 2016; 21(6):1359-1367. PubMed ID: 28039692
[TBL] [Abstract][Full Text] [Related]
18. Proposal for a unified CCN nomenclature.
Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
[TBL] [Abstract][Full Text] [Related]
19. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina.
Hughes JM; Kuiper EJ; Klaassen I; Canning P; Stitt AW; Van Bezu J; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Diabetologia; 2007 May; 50(5):1089-98. PubMed ID: 17333105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
